These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10784640)

  • 1. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
    Eisen A; Rebbeck TR; Wood WC; Weber BL
    J Clin Oncol; 2000 May; 18(9):1980-95. PubMed ID: 10784640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy.
    van Roosmalen MS; Verhoef LC; Stalmeier PF; Hoogerbrugge N; van Daal WA
    J Clin Oncol; 2002 Apr; 20(8):2092-100. PubMed ID: 11956270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer.
    Hermsen BB; van Diest PJ; Berkhof J; Menko FH; Gille JJ; Piek JM; Meijer S; Winters HA; Kenemans P; Mensdorff-Pouilly Sv; Verheijen RH
    Int J Cancer; 2006 Sep; 119(6):1412-8. PubMed ID: 16615107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.
    Contant CM; Menke-Pluijmers MB; Seynaeve C; Meijers-Heijboer EJ; Klijn JG; Verhoog LC; Tjong Joe Wai R; Eggermont AM; van Geel AN
    Eur J Surg Oncol; 2002 Sep; 28(6):627-32. PubMed ID: 12359199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
    Schrag D; Kuntz KM; Garber JE; Weeks JC
    N Engl J Med; 1997 May; 336(20):1465-71. PubMed ID: 9148160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.
    Batista LI; Lu KH; Beahm EK; Arun BK; Bodurka DC; Meric-Bernstam F
    BMC Cancer; 2008 Apr; 8():101. PubMed ID: 18410690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
    Dowdy SC; Stefanek M; Hartmann LC
    Am J Obstet Gynecol; 2004 Oct; 191(4):1113-23. PubMed ID: 15507929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic oophorectomy in women at increased cancer risk.
    Domchek SM; Rebbeck TR
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines.
    Julian-Reynier C; Eisinger F; Moatti JP; Sobol H
    Eur J Hum Genet; 2000 Mar; 8(3):204-8. PubMed ID: 10780786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.
    Grann VR; Panageas KS; Whang W; Antman KH; Neugut AI
    J Clin Oncol; 1998 Mar; 16(3):979-85. PubMed ID: 9508180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.
    Heemskerk-Gerritsen BA; Brekelmans CT; Menke-Pluymers MB; van Geel AN; Tilanus-Linthorst MM; Bartels CC; Tan M; Meijers-Heijboer HE; Klijn JG; Seynaeve C
    Ann Surg Oncol; 2007 Dec; 14(12):3335-44. PubMed ID: 17541692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of management options for women with a hereditary predisposition to ovarian cancer.
    Rosen B; Kwon J; Fung Kee Fung M; Gagliardi A; Chambers A;
    Gynecol Oncol; 2004 May; 93(2):280-6. PubMed ID: 15099934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylactic surgery in common hereditary cancer syndromes].
    Noguès C; Mouret-Fourme E
    Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
    Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
    JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Preventive Intervention of Hereditary Breast Cancer.
    Cao A; Huang L; Shao Z
    Adv Exp Med Biol; 2017; 1026():41-57. PubMed ID: 29282679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic surgery in hereditary breast/ovarian cancer syndrome.
    Levine DA; Gemignani ML
    Oncology (Williston Park); 2003 Jul; 17(7):932-41; discussion 946-8, 950-2. PubMed ID: 12886864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic mastectomy in women at high risk for breast cancer: indications and options].
    Scheufler O; Fritschen Uv
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):239-47. PubMed ID: 18716986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
    Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
    N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.